相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Metabolomics of Burkitt Lymphoma Mouse Models
Fengmin Yang et al.
PLOS ONE (2017)
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
Caterina Constantinou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function
Serafoula Filou et al.
BIOCHEMISTRY (2016)
Scavenger Receptor Class B Type I Regulates Plasma Apolipoprotein E Levels and Dietary Lipid Deposition to the Liver
Eleni A. Karavia et al.
BIOCHEMISTRY (2015)
Lack of LCAT reduces the LPS-neutralizing capacity of HDL and enhances LPS-induced inflammation in mice
Peristera-Ioanna Petropoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition
Eleni A. Karavia et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways
Xiaolei Han et al.
BIOLOGY OPEN (2015)
Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial
Evangelia Zvintzou et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations
Caterina Constantinou et al.
JOURNAL OF LIPID RESEARCH (2014)
HDL quality and functionality: what can proteins and genes predict?
Eleni A. Karavia et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2014)
HDL particle functionality as a primary pharmacological target for HDL-based therapies
Kyriakos T. Kypreos et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Unraveling the complexities of the HDL lipidome
Anatol Kontush et al.
JOURNAL OF LIPID RESEARCH (2013)
Qualitative characteristics of HDL in young patients of an acute myocardial infarction
Anthula E. Kavo et al.
ATHEROSCLEROSIS (2012)
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
Robert S. Rosenson et al.
JOURNAL OF LIPID RESEARCH (2012)
A biochemical fluorometric method for assessing the oxidative properties of HDL
Theodoros Kelesidis et al.
JOURNAL OF LIPID RESEARCH (2011)
The Human Serum Metabolome
Nikolaos Psychogios et al.
PLOS ONE (2011)
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
Eirini M. Tsompanidi et al.
ATHEROSCLEROSIS (2010)
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia
Kyriakos E. Kypreos
BIOCHEMISTRY (2008)
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Proteomic analysis of high-density lipoprotein
F Rezaee et al.
PROTEOMICS (2006)
Absorption and lipoprotein transport of sphingomyelin
A Nilsson et al.
JOURNAL OF LIPID RESEARCH (2006)
Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins
M Heller et al.
PROTEOMICS (2005)
Lipoproteomics II: Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
H Karlsson et al.
PROTEOMICS (2005)
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice
I Duivenvoorden et al.
DIABETES (2005)
Lipoproteomics I: Mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
H Karlsson et al.
PROTEOMICS (2005)
Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma
HR Tang et al.
ANALYTICAL BIOCHEMISTRY (2004)
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice
A Chroni et al.
BIOCHEMISTRY (2004)
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
A Onat et al.
ATHEROSCLEROSIS (2003)
Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo -: Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion
KE Kypreos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Analysis of the structure and function relationship of human apolipoprotein E in vivo, using adenovirus-mediated gene transfer
KE Kypreos et al.
FASEB JOURNAL (2001)
The amino-terminal 1-185 domain of ApoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and ApoE-deficient mice
KE Kypreos et al.
BIOCHEMISTRY (2001)
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter
AT Remaley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease
BF Asztalos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
